Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| SBI SECURITIES Co., Ltd.2024-09-09 · amended | 2.80% | +1.54pp |
| Evolution Capital Management LLC2024-09-05 · amended | 0.00% | no change |
| Evo Fund2024-09-05 · amended | 41.14% | -1.13pp |
| Evolution Capital Management LLC2024-09-02 · amended | 0.00% | no change |
| Evo Fund2024-09-02 · amended | 42.27% | -2.84pp |
| Evolution Capital Management LLC2024-08-30 · amended | 0.00% | no change |
| Evo Fund2024-08-30 · amended | 45.11% | +39.69pp |
| Evolution Capital Management LLC2024-08-28 · amended | 0.00% | no change |
| Evo Fund2024-08-28 · amended | 5.42% | -1.20pp |
| Evolution Capital Management LLC2024-08-20 · amended | 0.00% | no change |
| Evo Fund2024-08-20 · amended | 6.62% | no change |
| Evolution Capital Management LLC2024-08-19 · amended | 0.00% | no change |
| Evo Fund2024-08-19 · amended | 6.62% | -1.56pp |
| Evolution Capital Management LLC2024-08-16 · amended | 0.00% | no change |
| Evo Fund2024-08-16 · amended | 8.18% | -3.33pp |
| Haruhiko Morita2024-08-09 · amended | 0.92% | -0.23pp |
| Life Science Innovation Management Inc.2024-08-09 · amended | 12.25% | +3.28pp |
| Osamu Nureki2024-08-02 | 5.11% | -1.02pp |
| NUREKI OSAMU2024-08-02 | 6.13% | new |
| Evolution Capital Management LLC2024-07-31 · amended | 0.00% | no change |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.